23 May 2013
Keywords: prizm, pharma, saporin, cell, death, protein, patent
Article | 22 January 1996
Prizm Pharmaceuticals has received a notice of allowance for a US
patent on recombinant saporin, an enzyme that inhibits protein ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 January 1996
15 January 1996
29 January 1996
© 2013 thepharmaletter.com